ES2153457T3 - Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. - Google Patents
Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.Info
- Publication number
- ES2153457T3 ES2153457T3 ES95400613T ES95400613T ES2153457T3 ES 2153457 T3 ES2153457 T3 ES 2153457T3 ES 95400613 T ES95400613 T ES 95400613T ES 95400613 T ES95400613 T ES 95400613T ES 2153457 T3 ES2153457 T3 ES 2153457T3
- Authority
- ES
- Spain
- Prior art keywords
- benzoxazolinonas
- benzotiazolinonas
- alquil
- amino
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I): EN LA QUE R1, R2, R3, X Y N SON TALES COMO SE DEFINEN EN LA DESCRIPCION, SUS ISOMEROS OPTICOS, Y SUS SALES DE ADICION A UN ACIDO O UNA BASE FARMACEUTICAMENTE ACEPTABLE. MEDICAMENTOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9403298A FR2717810B1 (fr) | 1994-03-22 | 1994-03-22 | Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2153457T3 true ES2153457T3 (es) | 2001-03-01 |
Family
ID=9461264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95400613T Expired - Lifetime ES2153457T3 (es) | 1994-03-22 | 1995-03-21 | Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US5534511A (es) |
| EP (1) | EP0673933B1 (es) |
| JP (1) | JP2705788B2 (es) |
| CN (1) | CN1055924C (es) |
| AT (1) | ATE197450T1 (es) |
| AU (1) | AU680717B2 (es) |
| CA (1) | CA2145026A1 (es) |
| DE (1) | DE69519315T2 (es) |
| DK (1) | DK0673933T3 (es) |
| ES (1) | ES2153457T3 (es) |
| FI (1) | FI951297A7 (es) |
| FR (1) | FR2717810B1 (es) |
| GR (1) | GR3035175T3 (es) |
| NO (1) | NO304689B1 (es) |
| NZ (1) | NZ270760A (es) |
| PT (1) | PT673933E (es) |
| ZA (1) | ZA952333B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2717810B1 (fr) * | 1994-03-22 | 1996-04-26 | Adir | Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| WO1997004593A1 (fr) * | 1995-07-19 | 1997-02-06 | Kabushiki Kaisha Toshiba | Convertisseur de boite aux lettres |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| FR2755690B1 (fr) * | 1996-11-08 | 1998-12-18 | Adir | Nouveaux derives aminomethyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| AU760800B2 (en) * | 1997-10-24 | 2003-05-22 | Warner-Lambert Company | Method for treating disease-related or drug-induced dyskinesias |
| GB9725541D0 (en) * | 1997-12-02 | 1998-02-04 | Pharmacia & Upjohn Spa | Amino-benzothiazole derivatives |
| DE19812331A1 (de) * | 1998-03-20 | 1999-09-23 | Merck Patent Gmbh | Piperidinderivate |
| US20040192669A1 (en) | 2000-04-13 | 2004-09-30 | Rosenfeld Mark J. | Novel compounds for use in weight loss and appetite suppression in humans |
| US7794761B2 (en) * | 2000-04-13 | 2010-09-14 | Seroctin Research & Technology, Inc. | Methods for inducing anti-anxiety and calming effects in animals and humans |
| US7524877B2 (en) | 2003-11-20 | 2009-04-28 | Seroctin Research & Technology, Inc. | Compounds for use in weight loss and appetite suppression in humans |
| ES2332597T3 (es) | 2004-05-27 | 2010-02-09 | Ucb Pharma S.A. | Derivados de benzoxazolona, procedimientos para su preparacion y su uso. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2536749A1 (fr) * | 1982-11-25 | 1984-06-01 | Cerm Cent Europ Rech Mauvernay | (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique |
| US4554284A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones |
| US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
| FR2643634A1 (fr) * | 1989-02-28 | 1990-08-31 | Adir | Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2674524B1 (fr) * | 1991-03-25 | 1993-05-21 | Adir | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2717810B1 (fr) * | 1994-03-22 | 1996-04-26 | Adir | Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1994
- 1994-03-22 FR FR9403298A patent/FR2717810B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-20 CA CA002145026A patent/CA2145026A1/fr not_active Abandoned
- 1995-03-20 FI FI951297A patent/FI951297A7/fi unknown
- 1995-03-21 PT PT95400613T patent/PT673933E/pt unknown
- 1995-03-21 EP EP95400613A patent/EP0673933B1/fr not_active Expired - Lifetime
- 1995-03-21 NO NO950795A patent/NO304689B1/no not_active IP Right Cessation
- 1995-03-21 NZ NZ270760A patent/NZ270760A/en unknown
- 1995-03-21 DE DE69519315T patent/DE69519315T2/de not_active Expired - Fee Related
- 1995-03-21 US US08/407,238 patent/US5534511A/en not_active Expired - Fee Related
- 1995-03-21 DK DK95400613T patent/DK0673933T3/da active
- 1995-03-21 ES ES95400613T patent/ES2153457T3/es not_active Expired - Lifetime
- 1995-03-21 AT AT95400613T patent/ATE197450T1/de not_active IP Right Cessation
- 1995-03-21 AU AU14988/95A patent/AU680717B2/en not_active Ceased
- 1995-03-22 JP JP7062381A patent/JP2705788B2/ja not_active Expired - Lifetime
- 1995-03-22 CN CN95103078A patent/CN1055924C/zh not_active Expired - Fee Related
- 1995-03-22 ZA ZA952333A patent/ZA952333B/xx unknown
- 1995-12-08 US US08/569,576 patent/US5688820A/en not_active Expired - Fee Related
- 1995-12-08 US US08/569,568 patent/US5688811A/en not_active Expired - Fee Related
-
2000
- 2000-12-29 GR GR20000402864T patent/GR3035175T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1498895A (en) | 1995-09-28 |
| ZA952333B (en) | 1995-12-15 |
| FI951297L (fi) | 1995-09-23 |
| US5688811A (en) | 1997-11-18 |
| NO304689B1 (no) | 1999-02-01 |
| AU680717B2 (en) | 1997-08-07 |
| FI951297A0 (fi) | 1995-03-20 |
| FI951297A7 (fi) | 1995-09-23 |
| ATE197450T1 (de) | 2000-11-11 |
| DK0673933T3 (da) | 2001-01-02 |
| NZ270760A (en) | 1996-03-26 |
| CN1055924C (zh) | 2000-08-30 |
| US5534511A (en) | 1996-07-09 |
| NO951081D0 (no) | 1995-03-21 |
| CA2145026A1 (fr) | 1995-09-23 |
| DE69519315T2 (de) | 2001-05-31 |
| EP0673933B1 (fr) | 2000-11-08 |
| US5688820A (en) | 1997-11-18 |
| JPH07258233A (ja) | 1995-10-09 |
| DE69519315D1 (de) | 2000-12-14 |
| GR3035175T3 (en) | 2001-04-30 |
| NO951081L (no) | 1995-09-25 |
| FR2717810B1 (fr) | 1996-04-26 |
| JP2705788B2 (ja) | 1998-01-28 |
| EP0673933A1 (fr) | 1995-09-27 |
| FR2717810A1 (fr) | 1995-09-29 |
| CN1112114A (zh) | 1995-11-22 |
| PT673933E (pt) | 2001-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2081187T3 (es) | Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2190396T3 (es) | Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2071621T3 (es) | Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen. | |
| PA8568501A1 (es) | Compuestos oxo-azabiciclicos | |
| ES2142030T3 (es) | Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| ES2153457T3 (es) | Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| ES2148458T3 (es) | Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2167021T3 (es) | Derivados de acido 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasa de matriz. | |
| ES2153019T3 (es) | Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2130548T3 (es) | Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2183492T3 (es) | Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2133686T3 (es) | Nuevos derivados de benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2143833T3 (es) | Acidos y esteres de la diosmetina y composiciones farmaceuticas que los contienen. | |
| ES2127263T3 (es) | Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| ES2190574T3 (es) | Nuevos compuestos del indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2125963T3 (es) | Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| ES2078130T3 (es) | Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen. | |
| ES2157539T3 (es) | Derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| UY27001A1 (es) | Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos | |
| ES8800952A1 (es) | Un procedimiento para la preparacion de derivados de carbapenem. | |
| AR003093A1 (es) | Nuevos derivados de imidazol-n-bencildioxol, su procedimiento de preparacion, su aplicacion a titulo de medicamentos, composicionesfarmaceuticas y nueva utilizacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 673933 Country of ref document: ES |